160 related articles for article (PubMed ID: 30183475)
1. Enhancing the efficacy of glycolytic blockade in cancer cells
Wilson JJ; Chow KH; Labrie NJ; Branca JA; Sproule TJ; Perkins BRA; Wolf EE; Costa M; Stafford G; Rosales C; Mills KD; Roopenian DC; Hasham MG
Cancer Biol Ther; 2019; 20(2):169-182. PubMed ID: 30183475
[TBL] [Abstract][Full Text] [Related]
2. Molecular Determinant of DIDS Analogs Targeting RAD51 Activity.
Velic D; Demeyer A; Peterlini T; Benhelli-Mokrani H; Mathé-Allainmat M; Masson JY; Fleury F
Molecules; 2021 Sep; 26(18):. PubMed ID: 34576930
[TBL] [Abstract][Full Text] [Related]
3. Attenuating homologous recombination stimulates an AID-induced antileukemic effect.
Lamont KR; Hasham MG; Donghia NM; Branca J; Chavaree M; Chase B; Breggia A; Hedlund J; Emery I; Cavallo F; Jasin M; Rüter J; Mills KD
J Exp Med; 2013 May; 210(5):1021-33. PubMed ID: 23589568
[TBL] [Abstract][Full Text] [Related]
4. DIDS, a chemical compound that inhibits RAD51-mediated homologous pairing and strand exchange.
Ishida T; Takizawa Y; Kainuma T; Inoue J; Mikawa T; Shibata T; Suzuki H; Tashiro S; Kurumizaka H
Nucleic Acids Res; 2009 Jun; 37(10):3367-76. PubMed ID: 19336413
[TBL] [Abstract][Full Text] [Related]
5. Starving tumors: inhibition of glycolysis reduces viability of human endometrial and ovarian cancer cells and enhances antitumor efficacy of GnRH receptor-targeted therapies.
Reutter M; Emons G; Gründker C
Int J Gynecol Cancer; 2013 Jan; 23(1):34-40. PubMed ID: 23154267
[TBL] [Abstract][Full Text] [Related]
6. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
Wokoun U; Hellriegel M; Emons G; Gründker C
Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of DIDS analogues as efficient inhibitors of RAD51 involved in homologous recombination.
Demeyer A; Fonteneau L; Liennard M; Foyer C; Weigel P; Laurent AD; Lebreton J; Fleury F; Mathé-Allainmat M
Bioorg Med Chem Lett; 2023 May; 87():129261. PubMed ID: 36990245
[TBL] [Abstract][Full Text] [Related]
8. RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy.
Wiegmans AP; Miranda M; Wen SW; Al-Ejeh F; Möller A
Oncotarget; 2016 Sep; 7(37):60087-60100. PubMed ID: 27507046
[TBL] [Abstract][Full Text] [Related]
9. Interactions of the Rad51 inhibitor DIDS with human and bovine serum albumins: Optical spectroscopy and isothermal calorimetry approaches.
Velic D; Charlier C; Popova M; Jaunet-Lahary T; Bouchouireb Z; Henry S; Weigel P; Masson JY; Laurent A; Nabiev I; Fleury F
Biochimie; 2019 Dec; 167():187-197. PubMed ID: 31562898
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors.
Wanyan Y; Xu X; Liu K; Zhang H; Zhen J; Zhang R; Wen J; Liu P; Chen Y
Molecules; 2020 Dec; 25(23):. PubMed ID: 33297583
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.
Cheng G; Zielonka J; Dranka BP; McAllister D; Mackinnon AC; Joseph J; Kalyanaraman B
Cancer Res; 2012 May; 72(10):2634-44. PubMed ID: 22431711
[TBL] [Abstract][Full Text] [Related]
12. Genetic and Small Molecule Disruption of the AID/RAD51 Axis Similarly Protects Nonobese Diabetic Mice from Type 1 Diabetes through Expansion of Regulatory B Lymphocytes.
Ratiu JJ; Racine JJ; Hasham MG; Wang Q; Branca JA; Chapman HD; Zhu J; Donghia N; Philip V; Schott WH; Wasserfall C; Atkinson MA; Mills KD; Leeth CM; Serreze DV
J Immunol; 2017 Jun; 198(11):4255-4267. PubMed ID: 28461573
[TBL] [Abstract][Full Text] [Related]
13. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.
Hong SY; Hagen T
Biochem Biophys Res Commun; 2015 Oct; 465(4):838-44. PubMed ID: 26315267
[TBL] [Abstract][Full Text] [Related]
14. Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice.
Huang CC; Wang SY; Lin LL; Wang PW; Chen TY; Hsu WM; Lin TK; Liou CW; Chuang JH
Dis Model Mech; 2015 Oct; 8(10):1247-54. PubMed ID: 26398947
[TBL] [Abstract][Full Text] [Related]
15. Identification of the determinants of 2-deoxyglucose sensitivity in cancer cells by shRNA library screening.
Kobayashi H; Nishimura H; Matsumoto K; Yoshida M
Biochem Biophys Res Commun; 2015 Nov; 467(1):121-7. PubMed ID: 26403972
[TBL] [Abstract][Full Text] [Related]
16. Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51.
Lee JO; Kang MJ; Byun WS; Kim SA; Seo IH; Han JA; Moon JW; Kim JH; Kim SJ; Lee EJ; In Park S; Park SH; Kim HS
Breast Cancer Res; 2019 Oct; 21(1):115. PubMed ID: 31640742
[TBL] [Abstract][Full Text] [Related]
17. p53 is an important factor for the radiosensitization effect of 2-deoxy-D-glucose.
Sinthupibulyakit C; Grimes KR; Domann FE; Xu Y; Fang F; Ittarat W; St Clair DK; St Clair W
Int J Oncol; 2009 Sep; 35(3):609-15. PubMed ID: 19639181
[TBL] [Abstract][Full Text] [Related]
18. The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells.
Santidrián AF; Cosialls AM; Coll-Mulet L; Iglesias-Serret D; de Frias M; González-Gironès DM; Campàs C; Domingo A; Pons G; Gil J
Haematologica; 2007 Dec; 92(12):1631-8. PubMed ID: 18055986
[TBL] [Abstract][Full Text] [Related]
19. Entinostat combined with Fludarabine synergistically enhances the induction of apoptosis in TP53 mutated CLL cells via the HDAC1/HO-1 pathway.
Zhou Z; Fang Q; Li P; Ma D; Zhe N; Ren M; Chen B; He Z; Wang J; Zhong Q; Wang J
Life Sci; 2019 Sep; 232():116583. PubMed ID: 31226417
[TBL] [Abstract][Full Text] [Related]
20. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
Maschek G; Savaraj N; Priebe W; Braunschweiger P; Hamilton K; Tidmarsh GF; De Young LR; Lampidis TJ
Cancer Res; 2004 Jan; 64(1):31-4. PubMed ID: 14729604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
